B Group, Inc.
- SEC CIK
- 0002043476
- Latest filing
- Aug 14, 2026
APGE holding history
Apogee Therapeutics, Inc. in every 13F filed by B Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APGE overviewAll 13F holders of APGEFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −7,500−100.0% | Sold out | Holders |
| Q1 2026 | 7,500 | $631.3K | 0.5% | −12,500−62.5% | Reduced | Holders |
| Q4 2025 | 20,000 | $1.51M | 1.1% | −15,000−42.9% | Reduced | Holders |
| Q3 2025 | 35,000 | $1.39M | 1.3% | 00.0% | Unchanged | Holders |
| Q2 2025 | 35,000 | $1.52M | 1.3% | +5,000+16.7% | Added | Holders |
| Q1 2025 | 30,000 | $1.12M | 1.0% | +15,000+100.0% | Added | Holders |
| Q4 2024 | 15,000 | $679.5K | 0.4% | – | No prior filing | Holders |